(Q38002111)

26 August 2017

title

A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury (English)

1 reference

26 August 2017

0 references

traumatic brain injury

0 references

author name string

Leora Schiff

1

1 reference

26 August 2017

Nandini Hadker

2

1 reference

26 August 2017

Silvia Weiser

3

1 reference

26 August 2017

Carsten Rausch

4

1 reference

26 August 2017

language of work or name

1 reference

1 April 2012

1 reference

Molecular Diagnosis and Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

16

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

79-92

1 reference

Traumatic brain injuries evaluated in U.S. emergency departments, 1992-1994.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Incidence of traumatic brain injury in the United States, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Clinical Policy: Neuroimaging and Decisionmaking in Adult Mild Traumatic Brain Injury in the Acute Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Biomarkers in the clinical diagnosis and management of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Epidemiology of head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Diagnostic Biomarkers for Stroke: A Stroke Neurologist's Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Serum biochemical markers of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

An ELISA for glial fibrillary acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Glial fibrillary acidic protein is highly correlated with brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256432

Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22497529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22497529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03256432

1 reference

Dimensions Publication ID

26 August 2017

1034960973

0 references

1 reference